Goldman Sachs’s Biote Corp. Warrant BTMDW Stock Holding History

Goldman Sachs’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-157,815	Closed	-$66.7K	–	6208
2023 Q1	$66.7K	Hold	157,815	–	–	﹤0.01%	5512
2022 Q4	$39.5K	Hold	157,815	–	–	﹤0.01%	5626
2022 Q3	$54K	Hold	157,815	–	–	﹤0.01%	5794
2022 Q2	$68K	Hold	157,815	–	–	﹤0.01%	5964
2022 Q1	$87K	Hold	157,815	–	–	﹤0.01%	6149
2021 Q4	$114K	Hold	157,815	–	–	﹤0.01%	6097
2021 Q3	$126K	Hold	157,815	–	–	﹤0.01%	5869
2021 Q2	$153K	Buy	+157,815	New	+$136K	﹤0.01%	5846

Other funds holding BTMDW

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs's BTMDW Position: Q2 2023 in Review

Goldman Sachs sold out of Biote Corp. Warrant (BTMDW) in Q2 2023, closing a stake of 157,815 shares — an estimated $66.7K sold.

Goldman Sachs first reported a position in BTMDW in Q2 2021 and held it in 8 quarters. The position peaked at $153K in Q2 2021. 2 funds tracked by Wall St. Rank hold BTMDW as of Q2 2023.

Goldman Sachs reported no remaining Biote Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Goldman Sachs sold 157,815 Biote Corp. Warrant shares in Q2 2023, an estimated $66.7K.
Goldman Sachs first reported a position in Biote Corp. Warrant in Q2 2021 and held it in 8 quarters.
Goldman Sachs's Biote Corp. Warrant position peaked at $153K in Q2 2021.
2 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2023.

Based on Goldman Sachs's 13F filing for Q2 2023, filed 15 Aug 2023.